CMR Surgical Encouraged By First In-Human Series With Versius Robot
Executive Summary
There have been no adverse events reported from the first 30 laparoscopic surgeries performed with CMR Surgical's robotic platform Versius in a hospital in India.
You may also be interested in...
Market Brief: Global Market For Endoscopic Surgeries Will Reach $17.7Bn In 2023
The global market for endoscopic and pelvic surgery procedures is expected to reach $17.7bn in 2023, a CAGR of 6.4%, driven by patients' demand for less invasive surgeries and physicians' preference for minimally invasive surgeries versus open surgeries. By 2023, the number of general and pelvic endoscopic procedures performed globally will reach about 29.7 million, representing a CAGR of 3.6%.
CMR Surgical Launches Robotic System To Rival Intuitive’s Da Vinci
UK-based CMR Surgical has debuted its new portable robotic system Versius. "Inspired by the human arm,” it is expected to assist in surgeries on European patients beginning next year. Versius is set to rival Intuitive Surgical’s da Vinci robot systems, the current market leader in robotic surgery.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.